Salmi HA, Sarna S. Effect of silymarin on chemical, functional and morphological alterations of the liver. A double-blind controlled study.
Scand J Gastroenterol.
1982;17:517-521.
Feher J, Desk G, Muzes G, et al. Liver protective action of silymarin therapy in chronic alcoholic liver diseases [in Hungarian].
Orv Hetil.
1989;130:2723-2727.
Fintelmann V, Albert A. Proof of the therapeutic efficacy of LegalonW for toxic liver illnesses in a double-blind trial [translated from German].
Therapiewoche.
1980;30:5589-5594.
Trinchet JC, Coste T, Levy VG, et al. Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients [translated from French].
Gastroenterol Clin Biol.
1989;13:120-124.
Bunout D, Hirsch SB, Petermann MT, et al. Controlled study of the effect of silymarin on alcoholic liver disease [translated from Spanish].
Rev Med Chil.
1992;120:1370-1375.
Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
J Hepatol.
1989;9:105-113.
Benda L, Dittrich H, Ferenzi P, et al. The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis [translated from German].
Wien Klin Wochenschr.
1980;92:678-683.
Pares A, Planas R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.
J Hepatol.
1998;28:615-621.
Lang I, et al. Hepatoprotective and immunological effects of antioxidant drugs.
Tokai J Exp Clin Med.
1990;15:123-127.
Lang I, et al. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
Ital J Gastroenterol.
1990;22:283-287.
Lucena MI, Andrade RJ, de la Cruz JP, et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
Int J Clin Pharmacol Ther.
2002;40:2-8.
Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases.
Cochrane Database Syst Rev.
2001;CD002235.
Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
J Hepatol.
1999;30:1081-1089.
Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol and the liver: a review.
Alcohol.
1996;13:395-398.
Barak AJ, Beckenhauer HC, Junnila M, et al. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration.
Alcohol Clin Exp Res.
1993;17:552-555.
Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury.
J Nutr Sci Vitaminol.
1998;44:249-255.
Kanbak G, Inal M, Baycu C. Ethanol-induced hepatotoxicity and protective effect of betaine.
Cell Biochem Funct.
2001;19:281-285.
Lieber CS, DeCarli LM, Mak KM, et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin.
Hepatology.
1990;12:1390-1398.
Lieber CS, Leo MA, Mak KM, et al. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity.
Hepatology.
1985;5:561-572.
Lieber CS, Rubin E. Alcoholic fatty liver.
N Engl J Med.
1969;280:705-708.
Schuller-Perez A, Gonzalez San Martin F. A controlled study with polyunsaturated phosphatidylcholine compared to placebo in alcoholic steatosis of the liver [translated from German].
Med Welt.
1985;36:517-521.
Knuchel F. Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behavior and lipid composition of the serum [translated from German].
Med Welt.
1979;30:411-416.
Keung WM, Vallee BL. Kudzu root: an ancient Chinese source of modern antidipsotropic agents.
Phytochemistry.
1998;47:499-506.
Shebek J, Rindone JP. A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism.
J Altern Complement Med.
2000;6:45-48.
Bullock ML, Kiresuk TJ, Sherman RE, et al. A large, randomized, placebo-controlled study of auricular acupuncture for alcohol dependence.
J Subst Abuse Treat.
2002;22:71-77.
Sapir-Weise R, Berglund M, Frank A, et al. Acupuncture in alcoholism treatment: a randomized out-patient study.
Alcohol Alcohol.
1999;34:629-635.
Worner TM, Zeller B, Schwarz H, et al. Acupuncture fails to improve treatment outcome in alcoholics.
Drug Alcohol Depend.
1992;30:169-173.
Bullock ML, Umen AJ, Culliton PD, et al. Acupuncture treatment of alcoholic recidivism: a pilot study.
Alcohol Clin Exp Res.
1987;11:292-295.
Bullock ML, Culliton PD, Olander RT. Controlled trial of acupuncture for severe recidivist alcoholism.
Lancet.
1989;1:1435-1439.
Akhondzadeh S, Kashani L, Mobaseri M, et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.
J Clin Pharm Ther.
2001;26:369-373.
Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity.
Am J Clin Nutr.
1999;69:1071-1085.
Ni R, Leo MA, Zhao J, et al. Toxicity of beta-carotene and its exacerbation by acetaldehyde in HepG2 cells.
Alcohol.
2001;36:281-285.
Veh I, Chatterjee SS, Kiianmaa K, et al. Reduction of voluntary ethanol intake in alcohol-preferring AA-rats by kava extract. Presented at: International Congress and 49th Meeting of the Society for Medicinal Plant Research; September 2-6, 2001; Erlangen, Germany.
Markowitz JS, McRae AL, Sonne SC. Oral nutritional supplementation for the alcoholic patient: a brief overview.
Ann Clin Psychiatry.
2000;12:153-158.
European Scientific Cooperative on Phytotherapy.
Valerianae radix
[fascicule 4].
Monographs on the Medicinal Uses of Plant Drugs.
Exeter, UK: ESCOP;1996-1997:2.
Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyosine, cyproheptadine, valerian).
Postgrad Med J.
1995;71:227-228.
Chan TY. An assessment of the delayed effects associated with valerian overdose [letter].
Int J Clin Pharmacol Ther.
1998;36:569.
Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of Opuntia ficus indica
on symptoms of the alcohol hangover.
Arch Intern Med.
2004;164:1334-1340.
Pittler MH, White AR, Stevinson C, et al. Effectiveness of artichoke extract in preventing alcohol-induced hangovers: a randomized controlled trial.
CMAJ.
2003;169:1269-1273.
Trumpler F, Oez S, Stahli P, et al. Acupuncture for alcohol withdrawal: a randomized controlled trial.
Alcohol Alcohol.
2003;38:369-375.
Lukas SE, Penetar D, Berko J et al. An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting.
Alcohol Clin Exp Res.
2005;29:756-762.
Onyesom I. Honey-induced stimulation of blood ethanol elimination and its influence on serum triacylglycerol and blood pressure in man.
Ann Nutr Metab.
2005;49:319-24.
Kunz S, Schulz M, Lewitzky M, et al. Ear acupuncture for alcohol withdrawal in comparison with aromatherapy: a randomized-controlled trial.
Alcohol Clin Exp Res.
2007;31:436-442.
O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword.
J Am Coll Cardiol.
2007;50:1009-1014.
Rambaldi A, Jacobs B, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
Cochrane Database Syst Rev.
2007;CD003620.
Saller R, Brignoli R, Melzer J, et al. An updated systematic review with meta-analysis for the clinical evidence of silymarin.
Forsch Komplement Med.
2008;15:9-20.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.